USAPHC, Army Public Health Nursing Staff Officer

Slides:



Advertisements
Similar presentations
Tuberculosis Control in Substance Abuse Treatment Centers
Advertisements

Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
Contact Investigations
Contact Investigation for Tuberculosis Control
National Tuberculosis Controllers Association
Ebola Facts October 28, /28/14 Identify, Isolate, Inform: ED Evaluation and Management The following diagram provides guidance on evaluation and.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Determination of Case Classification for Reportable Medical Events John Ambrose, MPH, CHES Epidemiologist / Army DRSi Project Manager U.S. Army Public.
TB Contact Investigation
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
World Health Organization TB Case Definitions
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
TB Outbreak in Grand Forks
The ninth Technical Advisory Group and National TB Managers meeting
Diagnosis of TB.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Unit 5: IPT Isoniazid TB Preventive Therapy
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
1385 / 5 / 15 نشست سالانه برنامه كنترل سل شهريور Tuberculosis & Air Travel.
Overview of the School Health Program By Dr. O.O. Sekoni A presentation given at the training workshop on Improving Child Health in Ibadan Primary Schools.
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Best Practices for Case Finding in DRSi
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Head Start Health Regulations
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Evaluating Tuberculosis Surveillance and Action in an Urban and Rural Setting Kristine Lykens, Ph.D. In collaboration with Anita Kurian, MPH, MBBS Patrick.
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Determination of HIV Infection Among TB Patients in California, 2008 Darryl Kong 1, Jennifer Flood 1, Suzanne Marks 2, James Watt 1 1 California Department.
Medical Management of Contacts to Infectious Pulmonary Tuberculosis Alfred Lardizabal, MD New Jersey Medical School Global Tuberculosis Institute.
ANNOUNCEMENTS  Register for the Monthly Disease Surveillance Trainings to receive CMEs/CNEs: 1. Log-on or Request log-on ID/password:
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Progress of the Singapore TB Elimination Programme (STEP)
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Elements of the Cohort Review Approach Harvey L. Marx, Jr. Lisa Schutzenhofer TB Program Controller TB Program Manager.
State and Local STD Prevention Programs Prepared by Jim Lee, Senior Public Health Advisor, Texas Department of State Health Services and Melinda Salmon,
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Screening for TB.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Preparing for Cohort Review & Standard Forms for Cohort Presentation June 16, 2010 Kieran Hartsough.
Put Prevention Into Practice. Understand the PPIP Program What is Put Prevention Into Practice (PPIP)? What is Put Prevention Into Practice (PPIP)? Why.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
CIFOR Council to Improve Foodborne Outbreak Response CIFOR Guidelines and CIFOR Toolkit Donald J. Sharp, MD, DTM&H Food Safety Office National Center for.
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
TB is a leading killer of children, yet they remain utterly neglected
Investigation of Contacts of Persons with Infectious Tuberculosis, 2005 Division of Tuberculosis Elimination Centers for Disease Control and Prevention.
L.A. County Public Health Partnering with the Private Community to Control TB Myrna Mesrobian, MD, MPH.
TB Transmission What is TB? aTB is a disease caused by infection with a bacteria called Mycobacterium tuberculosis.
Introduction to Contact Investigation Process Amy Schmitt, BSN, RN Public Health Grand Rounds Tuberculosis November 19, 2015.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Increased # of AI/AN receiving in- home environmental assessment and trigger reduction education and asthma self-management education Increased # of tribal.
The Managerial Role In TB Interviewing and Large Scale Contact Investigations Eileen Napolitano for Mark Wolman NJ Medical School Global Tuberculosis Institute.
Whole-Genome Sequencing; It’s Not Just For Epis
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
This is an archived document.
This is an archived document.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Mark Lobato, MD Division of TB Elimination
UNAIDS/WHO POLICY ON HIV TESTING June 2004
Announcements All participants must register for the Monthly Disease Surveillance Trainings in order for us to provide CMEs: Log-on or Request log-on ID/password:
Using Whole Genome Sequencing Analysis in California
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Presentation transcript:

USAPHC, Army Public Health Nursing Staff Officer Conducting Contact Investigations for Tuberculosis July Epi-Tech Training Lakisha Flagg, MAJ, AN USAPHC, Army Public Health Nursing Staff Officer

Learning Objectives Define a TB contact interview/investigation Determine when to initiate a contact investigation Review of TB Contact Investigation Procedures (“10 Steps”) Identify relevant information sources Estimate period of infectivity Interview Case Develop plan for investigation Refine estimates Prioritize contacts Conducting field visits Conduct contact interviews Interview expansion Process evaluation Describe basic communication requirements Describe data collection process and goal of data management

What is a TB Contact Interview/Investigation Systematic process of case/contact: Identification Assessment Treatment Purpose Interaction with suspected or confirmed TB cases Information gathering, education, and knowledge reinforcement Essential component of TB control Identification and treatment of contacts Facilitate prevention of TB transmission

Components of a TB Contact Investigation Pre-Interview Data collection Establish priority of interviews Determination of infectious widow Interview Continued data collection/contact identification Assessment Education Collaboration Follow – Up Ongoing Collaboration & Process Evaluation Pulmonary, laryngeal, pleural Behavior – cough, singing, close social network The TB interview is initiated to identify contacts at risk of exposure to refer for medical evaluation for TB infection or disease. Because of this goal, only certain patients need to be interviewed. These include patients who Have been diagnosed with verified TB (excluding most forms of extrapulmonary TB, but including pleural effusion or miliary TB with cough and laryngeal TB); Are suspected of having pulmonary, laryngeal, or pleural TB; Have been diagnosed with any form of verified TB, abnormal chest x-ray, positive tuberculin skin test which indicates recent TB transmission (for example, a documented converter who has developed disease or a young child). The TB interview is conducted with individuals who may have put others at risk of contracting TB. In addition, if there is evidence of recent TB transmission, a source case investigation may be initiated. Like a contact investigation, this process attempts to locate a patient’s contacts, referred to as associates. In this case, the associate is viewed as the “source,” or the person who transmitted TB infection and not the recipient of TB infection due to prolonged exposure to the index case. For this reason, it is recommended that interviews be conducted with the following groups: parents or guardians of children 2 years of age and younger who have TB infection, and children 4 years of age and younger with TB disease or chest x-ray findings consistent with TB-related abnormalities. Guidelines for interviews for source case investigations are covered in Module 4.

Deciding When to Investigate Confirmed cases of infectious form of TB (e.g., pulmonary or laryngeal) Suspected TB cases, before confirmation Suspected TB cases with negative sputum smears Case has positive chest x-ray (CXR) Suspected TB cases with negative sputum smears, identified during outbreak investigation Contact Investigation GENERALLY not required when: -Noninfectious forms of TB disease -Cases younger than 10 years of age (Source Case Investigation) -*Defer to local policy when making determination to investigate

When to Investigate (cont.) Highest Priority: Highly infectious Symptomatic Settings conducive to transmission High risk for rapid development of TB disease Weakened immune systems Children younger than 5 years old Critical considerations: - Resources - Concurrent high-priority taskings Investigation of contacts with minimal findings to support TB diagnosis is not recommended.

CDC Contact Investigation Algorithm Source: CDC Investigations of Contact of Persons with Infectious Tuberculosis, 2005

Data Collection (Pre-Interview Phase) Purpose: Focuses investigation effort Assists in development of Interview Plan Pre-interview Information Sources: Medical Record Reporting provider Public health records (previous identification of case) Tuberculosis Genotyping Information Management System (TB GIMS)

Infectious Period Determination (Pre-Interview Period) Patient Information: Disease characteristics/site Onset of illness/symptoms Names of Contacts Exposure locations and recent travel Date of treatment initiation/Rx susceptibility Lab/Genotype results Demographics (including preferred language) Concurrent medical conditions (e.g., HIV) Potential communication barriers Estimation of infectious period Sputum Smear Positive Cases: 3 months before diagnosis or symptom development Symptomatic Sputum Smear Negative Cases: 3 Months “” Non-Symptomatic, Negative Smear Cases: 1 Month “”

Estimating the Beginning of the Infectious Period Characteristic of Index Case TB symptoms AFB sputum smear positive Cavitary chest radiograph Likely period of infectiousness Yes No 3 months before symptom onset or 1st positive finding consistent with TB disease, whichever is longer 4 weeks before date of suspected diagnosis 3 months before positive finding consistent with TB SOURCE: California Department of Health Services Tuberculosis Control Branch; California Tuberculosis Controllers Association. Contact Investigation Guidelines. Berkley, CA: California Department of Health Services; 1998.

Infectious Period & Prioritization (Pre-Interview Period) Criteria for determining the end of the infectious period: Effective Treatment for 2 weeks or more Symptom improvement Bacteriologic Response (3 negative AFB results) Exposure to contacts has ended Assigning Priorities to Contacts Exposure Age/Immune Status Factors/Degree of Infectiousness

Prioritization of Contacts (AFB Culture Positive) Source: CDC Investigations of Contact of Persons with Infectious Tuberculosis, 2005

Prioritization (AFB Culture Negative) Source: CDC Investigations of Contact of Persons with Infectious Tuberculosis, 2005

Factors Associated with Infectiousness Source: CDC Investigations of Contact of Persons with Infectious Tuberculosis, 2005

Factors for Infectiousness (cont.) Source: CDC Investigations of Contact of Persons with Infectious Tuberculosis, 2005

Interview Timelines Index (Source) Case First Interview should be conducted within ONE day of reporting Conduct in person Consider contact/safety precautions TB Clinic/Hospital Patient’s Home Minimum of TWO interviews (1-2 weeks apart) Contact Cases First Interview should be conducted within THREE days of identification Highest Priority first Site Visits Complete within THREE days of initial case interview Allows for verification of findings On average, 10 contacts are listed for each person with a case of infectious TB in the United States (50,59,89). Approximately 20%--30% of all contacts have LTBI, and 1% have TB disease (50). Of those contacts who ultimately will have TB disease, approximately half acquire disease in the first year after exposure (90,91). For this reason, contact investigations constitute a crucial prevention strategy

Interview Strategies Goals are identification of: WHERE infectious period was spent WHAT activities/events case was involved in WHO case spent time with during infectious period Considerations Complete Pre-Interview Activities FIRST Determine interview location Consider mental and physical condition of interviewee Proxy Interviews Anticipate and prepare for resistance Verify & Clarify Reinforce treatment instructions and risk mitigation strategies Allow time for questions Ensure confidentiality Educate

Initial Interviews Allows for initial collection of data related to contacts/exposure locations Permits face-to-face assessment After initial information collected Priority assignments should be reassessed Medical plan for diagnostic tests and treatment determined for contacts (e.g. Army TB Policy, 2013) Plan for follow-up Interview (highly recommended) Facilitates Recall Allows for reassessment Previous M. tuberculosis infection or disease and related treatment Contact’s verbal report and documentation of previous TST results Current symptoms of TB illness Medical conditions making TB disease more likely Mental health disorders Type, duration, and intensity of TB exposure Sociodemographic factors HIV status; contacts should be offered HIV counseling and testing if status unknown Information regarding social, emotional, and practical matters that might hinder participation

TB Interview Checklist

Developing a Plan for Investigation General purpose of Investigation plan: Refine estimates Prioritize contacts Symptomatic = Top Priority Likelihood of transmission Risk for TB disease development Prioritize identified places to conduct field visits Also consider… Development of communication plan for staff Clarification of jurisdictional issues Methods of investigation, assessment (TST/IGRA) Identification of stakeholders Potential media interest Schedule to review progress/barriers Elaborate on location based assessments – help in identifying contact that have not yet been identified Additional consideration includes - safety

Notes regarding TST/IGRA Testing Consider the following CDC guidelines: Do NOT retest previous positives Assess for symptoms, previous treatments Contacts found to have positive TST/IGRAs should be considered positive for LTBI (>5mm TST Reading = POSITIVE) Repeat testing for initial negatives 8-10 Weeks after exposure to case Consider Window Period Time between contacts last exposure to case and when TST/IGRA can reliably detect infection 2 to 8 weeks needed for body to mount detectable response to infection

Expanding the Investigation Conditions for Expansion: Achievement of program objectives/plan execution Unexpectedly large rate of infection or TB disease TB disease in any contacts who had been assigned low priority Infection in any contacts aged <5 years Contacts with change in TST/IGRA status from negative to positive Higher than expected prevalence of TB infection Calculation of TB Infection Prevalence for contacts Evidence of secondary transmission Local policy

Additional Considerations Investigations of: Social and Recreational Hospitals Workplace/School Settings Site Specific Number involved Exposure Duration and Proximity Resources

Data Management Management and epidemiologic analysis Program evaluation using performance indicators Process steps necessary for monitoring timeline objectives Assessment/reassessment of investigation strategy Number of index patients investigated for their sources Number of associates screened for TB disease Number of times a source is found

Communication Considerations Appropriate language level Cultural Awareness/Sensitivity Identification and mitigation of communication barriers Open-ended questions Restate/Summarize Demeanor Non-Verbal Communication

Confidentiality Essential to maintaining credibility and trust Constant attention required to maintain confidentiality Specific policies for release of confidential information related to contact investigations are recommended Informed Consent Policies & Training

Concluding a Contact Investigation Contact Investigation can be concluded if: Identified contacts have been assessed Contacts with LTBI have completed or are close to completing treatment No additional secondary cases of TB among identified contacts are found Follow local policy Next steps: Begin ‘after action review’ How many contacts identified/treated? How many contacts located, follow ups completed? Appropriate expansion? Training/resource needs? Effectiveness? Follow up plan?

Additional Training Essential for successful contact investigations Consider collaboration with local health care agencies Training Resources: TB101 for Healthcare Workers http://www.cdc.gov/tb/webcourses/TB101/intro.html Tools from CDC http://www.cdc.gov/tb/publications/eResources.htm

Reference Content adapted from: Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005; 54 (No. RR–15) http://www.cdc.gov/mmwr/pdf/rr/rr5415.pdf

Questions Army: USAPHC – Disease Epidemiology Program Aberdeen Proving Ground - MD Comm: (410) 436-7605   DSN:  584-7605 usarmy.apg.medcom-phc.mbx.disease-epidemiologyprogram13@mail.mil Navy: Contact your cognizant NEPMU NEPMU2: COMM: (757) 950-6600; DSN: (312) 377-6600 Email: NEPMU2NorfolkThreatAssessment@med.navy.mil NEPMU5: COMM: (619) 556-7070; DSN (312) 526-7070 Email: ThreatAssessment@med.navy.mil NEPMU6: COMM: (808) 471-0237; DSN: (315) 471-0237 Email: NEPMU6ThreatAssessment@med.navy.mil Air Force: Contact your MAJCOM PH or USAFSAM/PHR USAFSAM / PHR / Epidemiology Consult Service Wright-Patterson AFB, Ohio Comm: (937) 938-3207   DSN:  798-3207 episervices@wpafb.af.mil